Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM vs IV Oxytocin for PPH Prevention
NCT02080104Unknown
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH). Primary endpoint: Early Postpartum Hemorrhage at 24 hours. Status: unknown.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02080104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080104.